Skip to main content

Table 10 Global clinical assessment by the investigator in the PP set (no assessment in 103 patients)

From: Review of the literature and individual patients’ data meta-analysis on efficacy and tolerance of nitroxoline in the treatment of uncomplicated urinary tract infections

Assessment Investigator Patient
Group Nitroxoline (n = 148) Controls (n = 158) Nitroxoline (n = 148) Controls (n = 158)
Very good 115 (77.7%) 138 (87.3%) 109 (73.6%) 123 (77.8%)
Good 19 (12.8%) 13 (8.2%) 26 (17.6%) 29 (18.4%)
Satisfactory 4 (2.7%) 5 (3.2%) 5 (3.4%) 4 (2.5%)
Moderate 1 (0.7%) 0 (0%) 3 (2.0%) 1 (0.6%)
Insufficient 9 (6.1%) 2 (1.3%) 5 (3.4%) 1 (0.6%)
p-value* 0.006 0.143
  1. *comparison of nitroxoline vs. controls (ordered probit regression with random center effect).